Eliem Therapeutics Inc (ELYM)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Total Assets | 140.86M | 134.99M | 122.09M | 116.27M | 112.74M | 110.47M | 109.33M | 226.02M |
Total Current Assets | 133.17M | 134.39M | 120.17M | 114.24M | 112.43M | 110.26M | 109.22M | 226M |
Cash and Equivalents | 35.94M | 43.59M | 34.44M | 25.29M | 57.35M | 93.11M | 105.03M | 223.14M |
Total Non-Current Assets | 7.69M | 599k | 1.91M | 2.03M | 301k | 214k | 111k | 21k |
Total Liabilities | 6.5M | 6.28M | 5.23M | 3.77M | 2.99M | 2.87M | 2.95M | 3.74M |
Total Current Liabilities | 6.28M | 6.1M | 4.92M | 3.62M | 2.9M | 2.83M | 2.95M | 3.74M |
Total Non-Current Liabilities | 219k | 180k | 310k | 155k | 92k | 37k | 0 | 0 |
Common Equity | 3k | 3k | 3k | 3k | 3k | 3k | 3k | 7k |
Retained Earnings | -113.1M | -120.86M | -143.15M | -148.37M | -152.34M | -155.98M | -157.68M | -212.57M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 173.24M | 134.99M | 110.47M |
Total Current Assets | 148.25M | 134.39M | 110.26M |
Cash and Equivalents | 46.92M | 43.59M | 93.11M |
Total Non-Current Assets | 167.2M | 128.72M | 107.6M |
Total Liabilities | 6.04M | 6.28M | 2.87M |
Total Current Liabilities | 6.03M | 6.1M | 2.83M |
Total Non-Current Liabilities | 7k | 180k | 37k |
Total Equity | 167.2M | 128.72M | 107.6M |
Common Equity | 3k | 3k | 3k |
Retained Earnings | -75.62M | -120.86M | -155.98M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.